ORBUS THERAPEUTICS INC has a total of 21 patent applications. It decreased the IP activity by 87.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are LAUNX BIOMEDICAL CO LTD, IMPAX LABORATORIES INC and PHARMAMAX CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Israel | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Mexico | 2 | |
#9 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Levin Victor A | 15 |
#2 | Vakoula Alexander | 8 |
#3 | Yam Noymi | 8 |
#4 | Victor A Levin | 2 |
#5 | Levin Victor | 2 |
#6 | Alexander Vakoula | 1 |
#7 | Noymi Yam | 1 |
Publication | Filing date | Title |
---|---|---|
US2019133985A1 | Compositions and methods for use of eflornithine and derivatives and analogs thereof to treat cancers, including gliomas | |
MX2019003981A | Formulations for administration of eflornithine. | |
US2017273926A1 | Compositions and methods for use of eflornithine and derivatives and analogs thereof to treat cancers, including gliomas |